Item 7.01 Regulation FD Disclosure.

LogicBio Therapeutics, Inc. (the "Company") is furnishing as Exhibit 99.1 to this Current Report on Form 8-K a presentation, dated January 2021, which the Company intends to use from time to time in meetings with or presentations to investors.

The information in this Item 7.01 (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



Exhibit
  No.       Description

99.1          Investor Presentation, dated January 2021

104         The cover page from this Current Report on Form 8-K, formatted in
            Inline XBRL

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses